Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MD Diagnostics is a private UK medical device and diagnostics company that designs and manufactures handheld breath monitoring devices and respiratory pressure meters. Its commercial product portfolio includes carbon monoxide breath monitors for smoking cessation and carbon monoxide poisoning screening, hydrogen breath monitors for gastrointestinal intolerance and malabsorption testing, and respiratory pressure meters for mouth and nasal pressure assessment. The company markets products such as CO Check Pro, CO Check +, CO Check Pro Baby, H2 Check, RP Check, and SafeBreath consumables. Founded in 2008, the business emphasizes UK-based design and manufacturing and sells to healthcare providers including hospitals, smoking cessation clinics, dentists, allergy centers, and emergency services. MD Diagnostics appears to be a commercial-stage medtech company rather than a therapeutic biotech or drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MD Diagnostics.